
XFOR
X4 Pharmaceuticals
$3.94
+$0.09 (+2.34%)Jul 27, 2026
Key metrics
The numbers that frame XFOR today
- Market cap
- $371.62M
- P/E (TTM)
- -3.7
- EV / FCF
- -2.5
- Gross margin
- 81.8%
- EV / Sales
- 25.7
- ROIC
- -92.3%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $1.35
- 52wk High
- $4.83
Growth
Revenue and earnings trend for XFOR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XFOR
Is X4 Pharmaceuticals a good buy?
No. X4 Pharmaceuticals has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think X4 Pharmaceuticals is selling at a very high price.
What is the market capitalization of XFOR?
X4 Pharmaceuticals's market capitalization is $371.62M.
What is the P/E ratio for XFOR stock?
X4 Pharmaceuticals's current P/E ratio is -3.7.
What is the 52-week high for XFOR stock?
The 52-week high for X4 Pharmaceuticals is $4.83. The current close of $3.94 is 18.4% below that high.
What is the 52-week low for XFOR stock?
The 52-week low for X4 Pharmaceuticals is $1.35. The current close of $3.94 is 191.9% above that low.
Does XFOR stock pay dividends?
X4 Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XFOR?
X4 Pharmaceuticals's Debt / Equity ratio is 0.46.